News | December 05, 2021
Eris signs JV with MJ Biopharm to supply insulin in India
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
The company has has 10 existing labs in India
The funds will be used to scale up existing operations and launch new products
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
_256_384.jpg)
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Subscribe To Our Newsletter & Stay Updated
